https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-panel-may-review-gennovas-mrna-omicron-booster-vaccine/articleshow/99567069.cms
0
0
4/17/23 at 6:58pm
Organization
The Times of India
Author
Teena Thacker
Pune-based Gennova Biopharmaceuticals had submitted data to the drug regulator this month, amid an increase in the number of Covid-19 cases. Gennova, a subsidiary of Pune-based drugmaker Emcure, has developed an Omicron-specific vaccine GEMCOVAC-OM which has …
Create an account
or login to join the discussion